D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics and Molecular Biology D-index 68 Citations 12,652 142 World Ranking 1674 National Ranking 120

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Enzyme

Rudi Lurz spends much of his time researching Biochemistry, Molecular biology, Cell biology, Huntingtin and Peptide sequence. His Molecular biology research integrates issues from Plasmid, DNA, DNA replication, Biophysics and Mutant. His Plasmid study combines topics from a wide range of disciplines, such as Pilus and Escherichia coli.

His work carried out in the field of Cell biology brings together such families of science as Endothelial stem cell, Embryonic stem cell, Induced pluripotent stem cell and Reprogramming. The various areas that he examines in his Huntingtin study include Hsp90 and Geldanamycin. Rudi Lurz has researched Peptide sequence in several fields, including Protein structure and Relaxosome, Relaxase.

His most cited work include:

  • Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo (1129 citations)
  • EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. (944 citations)
  • Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington’s disease pathology (599 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Molecular biology, DNA, Biochemistry, Plasmid and Genetics. His Molecular biology study integrates concerns from other disciplines, such as Nucleic acid sequence, Gene, Mutant and DNA replication. His DNA study combines topics in areas such as Biophysics, Bacillus subtilis, Binding site and Cell biology.

His studies deal with areas such as Huntingtin and Induced pluripotent stem cell as well as Cell biology. Rudi Lurz combines subjects such as Nuclear protein, Protein aggregation and Fibrillogenesis with his study of Huntingtin. His work in the fields of Biochemistry, such as Peptide sequence, Protein structure and Nucleotide, overlaps with other areas such as Membrane protein.

He most often published in these fields:

  • Molecular biology (44.63%)
  • DNA (41.24%)
  • Biochemistry (28.81%)

What were the highlights of his more recent work (between 2008-2017)?

  • DNA (41.24%)
  • Molecular biology (44.63%)
  • Cell biology (16.95%)

In recent papers he was focusing on the following fields of study:

Rudi Lurz mainly focuses on DNA, Molecular biology, Cell biology, Biochemistry and Gene. His DNA research incorporates themes from Cytoplasm and Transcription factor. His studies deal with areas such as Biophysics, Mutation and Cytosol as well as Molecular biology.

Rudi Lurz has researched Cell biology in several fields, including Mutant, Capsid, Induced pluripotent stem cell, Oxidative Stress Pathway and Neuroscience. His Gene research entails a greater understanding of Genetics. His Long-term potentiation research incorporates elements of Fibril, Fibrillogenesis, Beta sheet and Small molecule.

Between 2008 and 2017, his most popular works were:

  • The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. (460 citations)
  • A double-hexameric MCM2-7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication (401 citations)
  • Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils (299 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Enzyme

Rudi Lurz mostly deals with Molecular biology, Cell biology, Peptide sequence, Peptide and Amyloid precursor protein. His studies in Molecular biology integrate themes in fields like DNA replication factor CDT1, Origin recognition complex, Eukaryotic DNA replication, Biophysics and Mutant. His Mutant study integrates concerns from other disciplines, such as Receptor, Teichoic acid, Cell envelope and DNA.

The study incorporates disciplines such as Reprogramming and Embryonic stem cell, Induced pluripotent stem cell in addition to Cell biology. His work deals with themes such as Protein structure, Missense mutation, Neprilysin and Small molecule, which intersect with Peptide sequence. His Peptide research is multidisciplinary, relying on both Promoter and Chromatin immunoprecipitation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo

Eberhard Scherzinger;Rudi Lurz;Mark Turmaine;Laura Mangiarini.
Cell (1997)

1816 Citations

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.

Dagmar E Ehrnhoefer;Jan Bieschke;Annett Boeddrich;Martin Herbst.
Nature Structural & Molecular Biology (2008)

1244 Citations

Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington’s disease pathology

Eberhard Scherzinger;Annie Sittler;Katja Schweiger;Volker Heiser.
Proceedings of the National Academy of Sciences of the United States of America (1999)

918 Citations

Accumulation of Mutant Huntingtin Fragments in Aggresome-like Inclusion Bodies as a Result of Insufficient Protein Degradation

Stephanie Waelter;Annett Boeddrich;Rudi Lurz;Eberhard Scherzinger.
Molecular Biology of the Cell (2001)

852 Citations

The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.

Alessandro Prigione;Beatrix Fauler;Rudi Lurz;Hans Lehrach.
Stem Cells (2010)

564 Citations

A double-hexameric MCM2-7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication

Cecile Evrin;Pippa Clarke;Juergen Zech;Rudi Lurz.
Proceedings of the National Academy of Sciences of the United States of America (2009)

515 Citations

Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington’s disease

Annie Sittler;Rudi Lurz;Gerhild Lueder;Josef Priller.
Human Molecular Genetics (2001)

489 Citations

Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils

Jan Bieschke;Martin Herbst;Martin Herbst;Thomas Wiglenda;Ralf P Friedrich.
Nature Chemical Biology (2012)

392 Citations

Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.

Volker Heiser;Eberhard Scherzinger;Annett Boeddrich;Eckhard Nordhoff.
Proceedings of the National Academy of Sciences of the United States of America (2000)

381 Citations

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay.

Volker Heiser;Sabine Engemann;Wolfgang Bröcker;Ilona Dunkel.
Proceedings of the National Academy of Sciences of the United States of America (2002)

288 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Rudi Lurz

Erich E. Wanker

Erich E. Wanker

Max Delbrück Center for Molecular Medicine

Publications: 83

Gillian P. Bates

Gillian P. Bates

University College London

Publications: 78

Juan C. Alonso

Juan C. Alonso

Spanish National Research Council

Publications: 70

Peter J. Christie

Peter J. Christie

The University of Texas at Austin

Publications: 46

Fernando de la Cruz

Fernando de la Cruz

Spanish National Research Council

Publications: 45

Gabriel Waksman

Gabriel Waksman

University College London

Publications: 44

Ronald Wetzel

Ronald Wetzel

University of Pittsburgh

Publications: 44

Erich Lanka

Erich Lanka

Max Planck Society

Publications: 43

Martin J. Loessner

Martin J. Loessner

ETH Zurich

Publications: 38

Christopher A. Ross

Christopher A. Ross

Johns Hopkins University School of Medicine

Publications: 35

Christopher M. Thomas

Christopher M. Thomas

University of Birmingham

Publications: 34

Michael R. Hayden

Michael R. Hayden

University of British Columbia

Publications: 33

Richard I. Morimoto

Richard I. Morimoto

Northwestern University

Publications: 32

Huilin Li

Huilin Li

Van Andel Institute

Publications: 31

Leslie M. Thompson

Leslie M. Thompson

University of California, Irvine

Publications: 30

David C. Rubinsztein

David C. Rubinsztein

University of Cambridge

Publications: 29

Trending Scientists

Paris Smaragdis

Paris Smaragdis

University of Illinois at Urbana-Champaign

Kai A. Konrad

Kai A. Konrad

Max Planck Institute for Tax Law and Public Finance

Peter Tufano

Peter Tufano

University of Oxford

Xiaodai Dong

Xiaodai Dong

University of Victoria

Patrick Wagner

Patrick Wagner

KU Leuven

Stephen Neidle

Stephen Neidle

University College London

Ramesh A. Shivdasani

Ramesh A. Shivdasani

Harvard University

Marit Reigstad

Marit Reigstad

University of Tromsø - The Arctic University of Norway

David J. Merritt

David J. Merritt

University of Western Australia

Mark S. Klempner

Mark S. Klempner

University of Massachusetts Medical School

Morten Otto Alexander Sommer

Morten Otto Alexander Sommer

Technical University of Denmark

Paul R. Rhomberg

Paul R. Rhomberg

University of Iowa

Michael Bizimis

Michael Bizimis

University of South Carolina

Gwendalyn J. Randolph

Gwendalyn J. Randolph

Washington University in St. Louis

Glenn Steele

Glenn Steele

Geisinger Health System

Denis Bernard

Denis Bernard

École Normale Supérieure

Something went wrong. Please try again later.